Pfizer Inc.
PFE Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
$PFE stock is featured in our Rob Bresnahan, Sector Weighted DC Insider, and Shelley Moore Capito strategies.
All StrategiesIncome
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of PFE by members of U.S. Congress
PFE Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
---
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
PFE Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
PFE Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in PFE holdings by institutional investors
Quarterly net insider trading by PFE's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$1,790,000 Aug 03, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
-
$1,880,000 Jul 20, 2026 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$4,420,000 Apr 17, 2026 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Trade (domestic/foreign)
-
$2,870,000 Mar 12, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
-
$3,730,000 Oct 20, 2025 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$4,240,000 Apr 21, 2025 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,600,000 Mar 21, 2025 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$3,740,000 Mar 21, 2025 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,070,000 Dec 11, 2024 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$2,450,000 Jul 19, 2024 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$3,000,000 Jan 19, 2024 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$4,050,000 Oct 20, 2023 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$2,480,000 Jul 20, 2023 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$3,050,000 Jan 20, 2023 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$3,250,000 Oct 20, 2022 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$3,480,000 Sep 02, 2022 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
-
$3,820,000 Sep 02, 2022 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
-
$2,980,000 Jan 20, 2022 Issue: Health Issues Medicare/Medicaid Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$1,780,000 Oct 20, 2021 Issue: Medicare/Medicaid Trade (domestic/foreign) Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$2,330,000 Jul 20, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$3,160,000 Apr 15, 2021 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid
-
$2,380,000 Jan 21, 2021 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Medicare/Medicaid
-
$1,930,000 Oct 20, 2020 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$2,470,000 Jul 20, 2020 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
-
$4,090,000 Apr 20, 2020 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid Budget/Appropriations
-
$2,300,000 Jan 31, 2020 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations
-
$1,650,000 Oct 22, 2019 Issue: Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$2,870,000 Jul 22, 2019 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues
-
$4,180,000 Jul 19, 2019 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$2,020,000 Apr 13, 2019 Issue: Budget/Appropriations Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Trade (domestic/foreign)
-
$2,780,000 Oct 21, 2018 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Alcohol and Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
-
$1,950,000 Oct 21, 2018 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Alcohol and Drug Abuse Medicare/Medicaid Budget/Appropriations
-
$4,650,000 Apr 20, 2018 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations Alcohol and Drug Abuse Taxation/Internal Revenue Code
-
$1,920,000 Jan 22, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Alcohol and Drug Abuse
-
$2,820,000 Oct 20, 2017 Issue: Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Alcohol and Drug Abuse Copyright/Patent/Trademark Health Issues Budget/Appropriations
-
$3,790,000 Aug 03, 2017 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Alcohol and Drug Abuse Medicare/Medicaid Budget/Appropriations Copyright/Patent/Trademark Health Issues
-
$2,110,000 Aug 03, 2017 Issue: Budget/Appropriations Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark Alcohol and Drug Abuse Taxation/Internal Revenue Code Medicare/Medicaid
-
$2,820,000 Jul 25, 2017 Issue: Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Alcohol and Drug Abuse Health Issues
-
$2,790,000 Oct 21, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Alcohol and Drug Abuse Taxation/Internal Revenue Code
-
$1,620,000 Oct 20, 2016 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Alcohol and Drug Abuse Health Issues Medicare/Medicaid Budget/Appropriations
-
$3,280,000 Apr 20, 2016 Issue: Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid Copyright/Patent/Trademark
-
$2,110,000 Jan 20, 2016 Issue: Trade (domestic/foreign) Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$2,380,000 Dec 16, 2015 Issue: Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products Medicare/Medicaid Alcohol and Drug Abuse
-
$1,750,000 Jul 21, 2015 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Consumer Issues/Safety/Products Medicare/Medicaid Copyright/Patent/Trademark Alcohol and Drug Abuse
-
$3,160,000 Apr 21, 2015 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Alcohol and Drug Abuse
-
$1,460,000 Jan 21, 2015 Issue: Trade (domestic/foreign) Consumer Issues/Safety/Products Medicare/Medicaid Alcohol and Drug Abuse Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$2,100,000 Oct 20, 2014 Issue: Copyright/Patent/Trademark Trade (domestic/foreign) Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$1,620,000 Jul 21, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products Trade (domestic/foreign) Alcohol and Drug Abuse
-
$3,190,000 Apr 21, 2014 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Alcohol and Drug Abuse Copyright/Patent/Trademark Health Issues
-
$2,090,000 Jan 21, 2014 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Alcohol and Drug Abuse Trade (domestic/foreign) Health Issues
-
$2,380,000 Oct 18, 2013 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Alcohol and Drug Abuse Taxation/Internal Revenue Code Consumer Issues/Safety/Products Trade (domestic/foreign)
-
$1,530,000 Jul 19, 2013 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign) Alcohol and Drug Abuse
-
$2,890,000 May 01, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Consumer Issues/Safety/Products Trade (domestic/foreign) Alcohol and Drug Abuse
-
$1,730,000 Jan 22, 2013 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Copyright/Patent/Trademark Defense Trade (domestic/foreign) Alcohol and Drug Abuse Animals
-
$2,600,000 Oct 22, 2012 Issue: Animals Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Defense Trade (domestic/foreign) Copyright/Patent/Trademark Alcohol and Drug Abuse
-
$2,330,000 Jul 20, 2012 Issue: Animals Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Alcohol and Drug Abuse Defense Copyright/Patent/Trademark Trade (domestic/foreign)
-
$3,550,000 May 25, 2012 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products Medicare/Medicaid Alcohol and Drug Abuse Defense Trade (domestic/foreign) Animals
-
$1,730,000 May 25, 2012 Issue: Consumer Issues/Safety/Products Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
-
$3,360,000 Oct 20, 2011 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$3,550,000 Jul 19, 2011 Issue: Consumer Issues/Safety/Products Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Copyright/Patent/Trademark Trade (domestic/foreign)
-
$3,790,000 Apr 20, 2011 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
-
$2,590,000 Jan 20, 2011 Issue: Health Issues Trade (domestic/foreign) Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Consumer Issues/Safety/Products
-
$4,150,000 Oct 20, 2010 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$6,200,000 Sep 21, 2010 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Agriculture Trade (domestic/foreign) Defense Budget/Appropriations Labor Issues/Antitrust/Workplace
-
$5,860,000 Sep 21, 2010 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Agriculture Defense Environment/Superfund
-
$2,250,000 Jul 20, 2010 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Defense Trade (domestic/foreign) Copyright/Patent/Trademark
-
$5,420,000 Oct 20, 2009 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Defense Agriculture
-
$5,340,000 Oct 20, 2009 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Defense Environment/Superfund Agriculture
-
$5,580,000 Jul 20, 2009 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Trade (domestic/foreign) Taxation/Internal Revenue Code Defense Labor Issues/Antitrust/Workplace
-
$3,250,000 Jan 21, 2009 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Agriculture Trade (domestic/foreign) Torts Environment/Superfund Defense
-
$3,070,000 Oct 27, 2008 Issue: Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Defense Trade (domestic/foreign) Consumer Issues/Safety/Products Agriculture Torts
-
$3,060,000 Jul 21, 2008 Issue: Torts Consumer Issues/Safety/Products Environment/Superfund Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Agriculture Defense Taxation/Internal Revenue Code
-
$2,800,000 Apr 21, 2008 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Consumer Issues/Safety/Products Taxation/Internal Revenue Code Defense Environment/Superfund Agriculture
-
$6,580,000 Feb 14, 2008 Issue: Budget/Appropriations Agriculture Trade (domestic/foreign) Science/Technology Consumer Issues/Safety/Products Environment/Superfund Copyright/Patent/Trademark Defense Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
-
$7,220,000 Aug 14, 2007 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Defense Trade (domestic/foreign) Budget/Appropriations Science/Technology Environment/Superfund
-
$5,800,000 Apr 27, 2007 Issue: Science/Technology Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Trade (domestic/foreign) Environment/Superfund Animals Torts
-
$4,500,000 Aug 14, 2006 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Consumer Issues/Safety/Products Animals Torts Medicare/Medicaid Budget/Appropriations Science/Technology
-
$3,490,000 Feb 14, 2006 Issue: Budget/Appropriations Medicare/Medicaid Consumer Issues/Safety/Products Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Agriculture Taxation/Internal Revenue Code Torts Science/Technology Animals
-
$3,000,000 Aug 15, 2005 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products Torts Science/Technology
-
$2,660,000 Feb 14, 2005 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products Torts Science/Technology
-
$3,000,000 Aug 16, 2004 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Torts Science/Technology Budget/Appropriations Consumer Issues/Safety/Products
-
$1,880,000 Feb 17, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products Torts Science/Technology Agriculture
-
$1,840,000 Aug 14, 2003 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Science/Technology Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products Torts
-
$1,700,000 Feb 14, 2003 Issue: Agriculture Copyright/Patent/Trademark Health Issues Budget/Appropriations Consumer Issues/Safety/Products
-
$90,000 Aug 14, 2002 Issue: Taxation/Internal Revenue Code
-
$1,900,000 Aug 14, 2002 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Science/Technology Consumer Issues/Safety/Products Budget/Appropriations Agriculture Trade (domestic/foreign) Health Issues Medicare/Medicaid
-
$60,000 Jun 25, 2002 Issue: Medicare/Medicaid Pharmacy
-
$60,000 Mar 12, 2002 Issue: Trade (domestic/foreign)
-
$40,000 Mar 05, 2002 Issue: Health Issues Medicare/Medicaid
-
$60,000 Mar 01, 2002 Issue: Trade (domestic/foreign) Aviation/Airlines/Airports Pharmacy Consumer Issues/Safety/Products
-
$20,000 Feb 14, 2002 Issue: Medicare/Medicaid
-
$40,000 Feb 14, 2002 Issue: Trade (domestic/foreign) Health Issues Taxation/Internal Revenue Code
-
$120,000 Feb 14, 2002 Issue: Transportation Health Issues
-
$20,000 Feb 12, 2002 Issue: Trade (domestic/foreign) Health Issues
-
$100,000 Jan 29, 2002 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid
-
$30,000 Jan 17, 2002 Issue: None
-
$1,840,000 Aug 14, 2001 Issue: Trade (domestic/foreign) Agriculture Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Consumer Issues/Safety/Products
-
$1,800,000 Feb 14, 2001 Issue: Transportation Trade (domestic/foreign) Financial Institutions/Investments/Securities Agriculture Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Animals
-
$1,640,000 Aug 14, 2000 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Financial Institutions/Investments/Securities Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Agriculture Transportation
-
$1,880,000 Feb 14, 2000 Issue: Transportation Taxation/Internal Revenue Code Trade (domestic/foreign) Financial Institutions/Investments/Securities Agriculture Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products
Former government officials who have lobbied for PFE
130 former government officials from 72 congressional offices at 31 lobbying firms have lobbied for PFE, most recently Jul 21, 2026.
-
Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg -
Nicholas Uehlecke House Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee
-
Nicolas Magallanes House Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander -
Christopher Wilcox House LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings -
Jeanne Haggerty Senate Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member -
Robert Butora Senate Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess -
Joshua Fendrick Senate Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters -
Gregory Nickerson Other Staff Dir., Ways&Means Subcom. on Select Reven.
PFE Estimated quarterly lobbying spending
PFE Revenue by Segment or Geography
By Segment
By Geography
PFE Income Statement
PFE Balance Sheet
PFE Cash Flow
U.S. Patents
New PFE patent grants
-
Patent Title: Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Sep. 13, 2016
-
Patent Title: Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Sep. 13, 2016
-
Patent Title: Anti-notch3 antibodies and antibody-drug conjugates Sep. 06, 2016
-
Patent Title: Platelet-derived growth factor b specific antibodies and compositions and uses thereof Aug. 30, 2016
-
Patent Title: Tandem purification of proteins Aug. 30, 2016
-
Patent Title: 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides Aug. 30, 2016
-
Patent Title: Process for annealing amorphous atorvastatin Aug. 30, 2016
-
Patent Title: Antibody to gdf8 and uses thereof Aug. 09, 2016
-
Patent Title: Anti-tofacitinib antibodies and uses thereof for drug monitoring Aug. 09, 2016
-
Patent Title: Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Aug. 02, 2016
-
Patent Title: Vectors for expression of prostate-associated antigens Aug. 02, 2016
-
Patent Title: 2-thiopyrimidinones Jul. 26, 2016
-
Patent Title: Dispensing device Jul. 26, 2016
-
Patent Title: Indole and indazole compounds that activate ampk Jul. 19, 2016
-
Patent Title: Anti-efna4 antibody-drug conjugates Jul. 05, 2016
-
Patent Title: Processes for the preparation of isothiazole derivatives Jun. 21, 2016
-
Patent Title: Use of ghrelin receptor inverse agonists or antagonists for treating sleep disorders Jun. 21, 2016
-
Patent Title: Processes for preparing peptide conjugates and linkers May. 31, 2016
-
Patent Title: Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr May. 17, 2016
-
Patent Title: Hydroxamic acid derivatives useful as antibacterial agents May. 17, 2016
-
Patent Title: Human antibodies that bind human madcam May. 03, 2016
-
Patent Title: Selective androgen receptor modulators May. 03, 2016
-
Patent Title: Tropomyosin-related kinase inhibitors May. 03, 2016
-
Patent Title: 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides Apr. 19, 2016
-
Patent Title: Device for dispensing a plurality of unitary doses of dry powder, and inhaler comprising such device Apr. 19, 2016
-
Patent Title: Recombinant virus-like particles encoded by multi-gene vector Apr. 12, 2016
-
Patent Title: Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hepatanoic acid Apr. 12, 2016
-
Patent Title: Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Apr. 12, 2016
-
Patent Title: Enhanced stability of novel liquid compositions Apr. 12, 2016
-
Patent Title: Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction Apr. 05, 2016
-
Patent Title: Triazine derivatives Mar. 29, 2016
-
Patent Title: Diacylglycerol acyltransferase 2 inhibitors Mar. 29, 2016
-
Patent Title: Purine derivatives Mar. 22, 2016
-
Patent Title: Antagonists of prostaglandin ep3 receptor Mar. 08, 2016
-
Patent Title: Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Feb. 16, 2016
-
Patent Title: Dihydropyrrolopyrimidine derivatives Feb. 16, 2016
-
Patent Title: Cytotoxic peptides and antibody drug conjugates thereof Feb. 02, 2016
-
Patent Title: Solid forms of a transthyretin dissociation inhibitor Feb. 02, 2016
-
Patent Title: Anti-glucagon receptor antibodies and pharmaceutical compositions thereof Feb. 02, 2016
-
Patent Title: Nucleic acids encoding antibodies to ccr2 Jan. 19, 2016
-
Patent Title: Antibodies to insulin-like growth factor i receptor Jan. 12, 2016
-
Patent Title: Substituted phenyl hexahydropyrano[3,4- Jan. 12, 2016
-
Patent Title: Substituted amide compounds Jan. 05, 2016
-
Patent Title: Human monoclonal antibodies to activin receptor-like kinase-1 Dec. 29, 2015
-
Patent Title: N-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia Dec. 08, 2015
-
Patent Title: Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders Dec. 01, 2015
-
Patent Title: Hexahydropyrano[3,4- Dec. 01, 2015
-
Patent Title: Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders Nov. 24, 2015
-
Patent Title: Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Nov. 24, 2015
-
Patent Title: N1/n2-lactam acetyl-coa carboxylase inhibitors Nov. 10, 2015
Government Contracts
Federal grants, loans, and purchases
- $358,740 2026-06-08 00:00:00 Agency: Department of Health and Human Services
- $4,607,967 2026-05-29 00:00:00 Agency: Department of Health and Human Services
- $381,401 2026-05-29 00:00:00 Agency: Department of Health and Human Services
- $542,605 2026-05-15 00:00:00 Agency: Department of Health and Human Services
- $187,561,182 2026-03-27 00:00:00 Agency: Department of Health and Human Services
- $11 2025-09-11 00:00:00 Agency: Department of Defense
- $546 2025-09-10 00:00:00 Agency: Department of Defense
- $47 2025-09-09 00:00:00 Agency: Department of Defense
- $93 2025-09-08 00:00:00 Agency: Department of Defense
- $93 2025-09-08 00:00:00 Agency: Department of Defense
- $93 2025-09-05 00:00:00 Agency: Department of Defense
- $744 2025-09-05 00:00:00 Agency: Department of Defense
- $27 2025-09-05 00:00:00 Agency: Department of Defense
- $302 2025-09-05 00:00:00 Agency: Department of Defense
- $546 2025-09-05 00:00:00 Agency: Department of Defense
- $23 2025-09-04 00:00:00 Agency: Department of Defense
- $23 2025-09-04 00:00:00 Agency: Department of Defense
- $187 2025-09-04 00:00:00 Agency: Department of Defense
- $546 2025-09-04 00:00:00 Agency: Department of Defense
- $23 2025-09-04 00:00:00 Agency: Department of Defense
- $25 2025-09-03 00:00:00 Agency: Department of Defense
- $298 2025-09-03 00:00:00 Agency: Department of Defense
- $23 2025-09-03 00:00:00 Agency: Department of Defense
- $47 2025-09-03 00:00:00 Agency: Department of Defense
- $25 2025-09-03 00:00:00 Agency: Department of Defense
- $77 2025-09-03 00:00:00 Agency: Department of Defense
- $72 2025-09-03 00:00:00 Agency: Department of Defense
- $48 2025-09-03 00:00:00 Agency: Department of Defense
- $15 2025-09-03 00:00:00 Agency: Department of Defense
- $23 2025-09-03 00:00:00 Agency: Department of Defense
- $25 2025-09-03 00:00:00 Agency: Department of Defense
- $23 2025-09-03 00:00:00 Agency: Department of Defense
- $47 2025-09-03 00:00:00 Agency: Department of Defense
- $70 2025-09-03 00:00:00 Agency: Department of Defense
- $327 2025-09-03 00:00:00 Agency: Department of Defense
- $153 2025-09-03 00:00:00 Agency: Department of Defense
- $363 2025-09-03 00:00:00 Agency: Department of Defense
- $159 2025-09-03 00:00:00 Agency: Department of Defense
- $47 2025-09-02 00:00:00 Agency: Department of Defense
- $93 2025-09-02 00:00:00 Agency: Department of Defense
- $23 2025-09-02 00:00:00 Agency: Department of Defense
- $93 2025-09-02 00:00:00 Agency: Department of Defense
- $23 2025-09-02 00:00:00 Agency: Department of Defense
- $23 2025-09-02 00:00:00 Agency: Department of Defense
- $187 2025-09-02 00:00:00 Agency: Department of Defense
- $23 2025-09-02 00:00:00 Agency: Department of Defense
- $23 2025-09-02 00:00:00 Agency: Department of Defense
- $234 2025-09-02 00:00:00 Agency: Department of Defense
- $72 2025-09-02 00:00:00 Agency: Department of Defense
- $701 2025-08-28 00:00:00 Agency: Department of Defense
Government Contracts
Estimated quarterly amount awarded to PFE from public contracts
PFE News
Recent insights relating to PFE
CNBC Recommendations
Recent picks made for PFE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PFE
PFE Analyst Ratings
PFE Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
PFE Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $PFE stock a Buy, Sell, or Hold?
- What is the price target for $PFE stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
PFE Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $PFE stock?
- Who owns the most shares of $PFE stock?
- What funds own $PFE stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
PFE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PFE Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
About PFE
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
- Address New York, NY
- Market Cap 160.6 billion
- Employees 75,000
- Industrial Classification Pharmaceutical Preparations
Pfizer Inc. (PFE) Historical Stock Prices
Pfizer Inc. (PFE) closed at $28.18 on September 23, 2026. Over the past year its adjusted close ranged from $22.05 to $29.02. Daily prices go back to January 2, 2014, 3,200 trading days in all.
- 1 month+0.75%
- 3 months+19.28%
- Year to date+19.05%
- 1 year+25.01%
- 3 years+4.61%
- 5 years-16.36%
- Max+69.29%
See every congressional and insider trade on the PFE price chart
Quiver Premium charts PFE's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | 27.96 | 28.23 | 27.84 | 28.18 | 28.18 | 33,812,863 |
| Sep 22, 2026 | 27.74 | 28.00 | 27.49 | 27.93 | 27.93 | 26,669,292 |
| Sep 21, 2026 | 27.65 | 27.92 | 27.53 | 27.74 | 27.74 | 28,776,627 |
| Sep 18, 2026 | 27.64 | 27.66 | 27.34 | 27.66 | 27.66 | 75,593,387 |
| Sep 17, 2026 | 27.62 | 27.81 | 27.55 | 27.64 | 27.64 | 29,013,808 |
| Sep 16, 2026 | 27.64 | 27.69 | 27.36 | 27.46 | 27.46 | 26,046,156 |
| Sep 15, 2026 | 27.61 | 27.66 | 27.25 | 27.55 | 27.55 | 40,435,888 |
| Sep 14, 2026 | 28.08 | 28.19 | 27.68 | 27.72 | 27.72 | 28,571,580 |
| Sep 11, 2026 | 27.80 | 27.85 | 27.42 | 27.72 | 27.72 | 25,557,178 |
| Sep 10, 2026 | 27.69 | 27.75 | 27.40 | 27.65 | 27.65 | 28,813,565 |
| Sep 9, 2026 | 27.76 | 27.98 | 27.57 | 27.78 | 27.78 | 29,135,329 |
| Sep 8, 2026 | 28.02 | 28.14 | 27.71 | 27.79 | 27.79 | 31,772,942 |
| Sep 4, 2026 | 28.58 | 28.69 | 28.38 | 28.45 | 28.45 | 23,791,956 |
| Sep 3, 2026 | 29.09 | 29.21 | 28.44 | 28.81 | 28.81 | 26,724,290 |
| Sep 2, 2026 | 28.79 | 29.09 | 28.70 | 29.02 | 29.02 | 39,277,907 |
| Sep 1, 2026 | 28.82 | 29.09 | 28.46 | 28.55 | 28.55 | 42,493,395 |
| Aug 31, 2026 | 27.85 | 28.70 | 27.64 | 28.46 | 28.46 | 45,930,349 |
| Aug 28, 2026 | 28.00 | 28.02 | 27.77 | 27.96 | 27.96 | 27,183,853 |
| Aug 27, 2026 | 27.97 | 28.18 | 27.83 | 28.02 | 28.02 | 31,174,426 |
| Aug 26, 2026 | 28.44 | 28.50 | 28.14 | 28.30 | 28.30 | 35,069,969 |
| Aug 25, 2026 | 27.91 | 28.58 | 27.84 | 28.57 | 28.57 | 31,915,704 |
| Aug 24, 2026 | 28.10 | 28.16 | 27.81 | 27.97 | 27.97 | 23,845,604 |
| Aug 21, 2026 | 27.77 | 28.43 | 27.66 | 28.07 | 28.07 | 37,109,565 |
| Aug 20, 2026 | 28.00 | 28.16 | 27.64 | 27.79 | 27.79 | 29,297,031 |
| Aug 19, 2026 | 27.60 | 28.43 | 27.58 | 28.24 | 28.24 | 59,804,172 |
| Aug 18, 2026 | 27.15 | 27.39 | 27.10 | 27.25 | 27.25 | 34,660,086 |
| Aug 17, 2026 | 26.76 | 27.02 | 26.55 | 26.87 | 26.87 | 29,261,200 |
| Aug 14, 2026 | 26.66 | 26.91 | 26.42 | 26.79 | 26.79 | 23,174,152 |
| Aug 13, 2026 | 26.49 | 26.95 | 26.41 | 26.80 | 26.80 | 35,355,834 |
| Aug 12, 2026 | 26.39 | 26.43 | 26.18 | 26.31 | 26.31 | 32,591,426 |
| Aug 11, 2026 | 26.94 | 27.20 | 26.47 | 26.62 | 26.62 | 37,943,593 |
| Aug 10, 2026 | 26.59 | 27.19 | 26.52 | 27.05 | 27.05 | 49,786,755 |
| Aug 7, 2026 | 26.22 | 26.76 | 26.05 | 26.76 | 26.76 | 42,744,071 |
| Aug 6, 2026 | 26.01 | 26.20 | 25.81 | 26.20 | 26.20 | 51,074,467 |
| Aug 5, 2026 | 25.50 | 25.81 | 25.30 | 25.81 | 25.81 | 47,058,338 |
| Aug 4, 2026 | 25.04 | 25.64 | 24.70 | 25.41 | 25.41 | 62,189,547 |
| Aug 3, 2026 | 25.15 | 25.39 | 24.86 | 25.03 | 25.03 | 40,645,813 |
| Jul 31, 2026 | 24.82 | 25.18 | 24.67 | 25.01 | 25.01 | 45,080,173 |
| Jul 30, 2026 | 24.84 | 24.98 | 24.55 | 24.91 | 24.91 | 44,954,469 |
| Jul 29, 2026 | 25.35 | 25.37 | 25.06 | 25.15 | 25.15 | 30,394,967 |
| Jul 28, 2026 | 24.97 | 25.50 | 24.94 | 25.25 | 25.25 | 49,942,743 |
| Jul 27, 2026 | 24.57 | 24.88 | 24.44 | 24.67 | 24.67 | 38,355,183 |
| Jul 24, 2026$0.43 dividend | 24.62 | 24.75 | 24.51 | 24.54 | 24.54 | 28,905,660 |
| Jul 23, 2026 | 24.89 | 25.10 | 24.75 | 25.01 | 24.58 | 30,876,684 |
| Jul 22, 2026 | 25.18 | 25.19 | 24.78 | 24.82 | 24.39 | 32,988,263 |
| Jul 21, 2026 | 24.76 | 25.00 | 24.64 | 24.94 | 24.51 | 27,328,847 |
| Jul 20, 2026 | 25.09 | 25.16 | 24.72 | 24.75 | 24.32 | 38,685,891 |
| Jul 17, 2026 | 25.40 | 25.65 | 24.97 | 25.05 | 24.62 | 45,629,587 |
| Jul 16, 2026 | 24.94 | 25.36 | 24.86 | 25.14 | 24.71 | 49,989,988 |
| Jul 15, 2026 | 24.34 | 24.82 | 24.31 | 24.82 | 24.39 | 44,162,477 |
| Jul 14, 2026 | 24.37 | 24.43 | 24.14 | 24.25 | 23.83 | 40,863,319 |
| Jul 13, 2026 | 24.28 | 24.72 | 24.23 | 24.48 | 24.06 | 42,953,402 |
| Jul 10, 2026 | 24.34 | 24.41 | 24.09 | 24.17 | 23.75 | 27,523,178 |
| Jul 9, 2026 | 24.11 | 24.30 | 24.01 | 24.25 | 23.83 | 29,190,482 |
| Jul 8, 2026 | 24.05 | 24.37 | 23.89 | 24.05 | 23.64 | 38,181,252 |
| Jul 7, 2026 | 24.05 | 24.35 | 23.93 | 24.07 | 23.66 | 44,101,385 |
| Jul 6, 2026 | 24.16 | 24.20 | 23.62 | 23.72 | 23.31 | 58,576,093 |
| Jul 2, 2026 | 24.15 | 24.57 | 24.13 | 24.32 | 23.90 | 53,138,979 |
| Jul 1, 2026 | 24.15 | 24.24 | 23.74 | 23.88 | 23.47 | 49,385,240 |
| Jun 30, 2026 | 24.43 | 24.46 | 23.78 | 24.08 | 23.66 | 60,046,006 |
| Jun 29, 2026 | 24.29 | 24.50 | 24.10 | 24.37 | 23.95 | 47,527,951 |
| Jun 26, 2026 | 23.74 | 24.35 | 23.74 | 24.29 | 23.87 | 59,958,944 |
| Jun 25, 2026 | 24.19 | 24.34 | 23.62 | 23.67 | 23.26 | 57,957,602 |
| Jun 24, 2026 | 24.80 | 25.11 | 23.93 | 24.04 | 23.63 | 76,962,612 |
| Jun 23, 2026 | 24.99 | 25.23 | 24.69 | 24.72 | 24.29 | 82,009,210 |
| Jun 22, 2026 | 25.22 | 25.30 | 24.96 | 25.08 | 24.65 | 41,119,106 |
| Jun 18, 2026 | 25.58 | 25.66 | 24.94 | 25.21 | 24.78 | 119,614,339 |
| Jun 17, 2026 | 26.02 | 26.28 | 25.86 | 25.92 | 25.47 | 31,117,475 |
| Jun 16, 2026 | 26.05 | 26.13 | 25.70 | 26.04 | 25.59 | 32,829,572 |
| Jun 15, 2026 | 26.25 | 26.42 | 25.98 | 26.00 | 25.55 | 34,194,148 |
| Jun 12, 2026 | 26.29 | 26.49 | 26.11 | 26.21 | 25.76 | 38,772,994 |
| Jun 11, 2026 | 25.79 | 26.48 | 25.79 | 26.17 | 25.72 | 45,268,705 |
| Jun 10, 2026 | 25.80 | 25.85 | 25.58 | 25.60 | 25.16 | 30,376,260 |
| Jun 9, 2026 | 25.73 | 25.88 | 25.47 | 25.70 | 25.26 | 35,273,222 |
| Jun 8, 2026 | 25.97 | 26.21 | 25.60 | 25.62 | 25.18 | 42,028,801 |
| Jun 5, 2026 | 25.85 | 26.21 | 25.79 | 26.04 | 25.59 | 32,218,530 |
| Jun 4, 2026 | 25.67 | 26.01 | 25.61 | 25.69 | 25.25 | 31,272,004 |
| Jun 3, 2026 | 25.43 | 25.62 | 25.29 | 25.34 | 24.90 | 30,957,066 |
| Jun 2, 2026 | 25.60 | 25.70 | 25.27 | 25.55 | 25.11 | 31,295,718 |
| Jun 1, 2026 | 25.90 | 25.91 | 25.48 | 25.63 | 25.19 | 35,553,597 |
| May 29, 2026 | 26.19 | 26.24 | 25.93 | 26.18 | 25.73 | 48,284,181 |
| May 28, 2026 | 26.16 | 26.28 | 26.01 | 26.14 | 25.69 | 25,651,799 |
| May 27, 2026 | 25.85 | 26.54 | 25.85 | 26.21 | 25.76 | 39,024,689 |
| May 26, 2026 | 25.87 | 25.90 | 25.66 | 25.85 | 25.41 | 29,084,737 |
| May 22, 2026 | 26.00 | 26.15 | 25.76 | 25.90 | 25.45 | 22,320,030 |
| May 21, 2026 | 25.77 | 25.96 | 25.57 | 25.95 | 25.50 | 20,181,537 |
| May 20, 2026 | 25.76 | 26.02 | 25.67 | 25.79 | 25.35 | 35,574,177 |
| May 19, 2026 | 25.30 | 25.96 | 25.24 | 25.66 | 25.22 | 41,036,716 |
| May 18, 2026 | 25.32 | 25.39 | 25.19 | 25.33 | 24.89 | 34,111,285 |
| May 15, 2026 | 25.75 | 25.83 | 25.24 | 25.33 | 24.89 | 37,110,083 |
| May 14, 2026 | 26.07 | 26.10 | 25.72 | 25.75 | 25.31 | 24,102,664 |
| May 13, 2026 | 25.80 | 26.09 | 25.64 | 25.96 | 25.51 | 39,419,955 |
| May 12, 2026 | 25.82 | 26.09 | 25.74 | 25.87 | 25.43 | 26,819,525 |
| May 11, 2026 | 25.79 | 26.18 | 25.68 | 25.81 | 25.37 | 43,557,962 |
| May 8, 2026$0.43 dividend | 26.16 | 26.20 | 25.60 | 25.68 | 25.24 | 38,903,356 |
| May 7, 2026 | 26.51 | 26.72 | 26.16 | 26.48 | 25.59 | 48,345,971 |
| May 6, 2026 | 26.56 | 26.68 | 26.21 | 26.53 | 25.64 | 40,357,069 |
| May 5, 2026 | 26.59 | 26.75 | 26.01 | 26.45 | 25.57 | 57,656,105 |
| May 4, 2026 | 26.24 | 26.51 | 26.15 | 26.30 | 25.42 | 34,583,353 |
| May 1, 2026 | 26.60 | 26.61 | 26.29 | 26.33 | 25.45 | 29,318,723 |
| Apr 30, 2026 | 26.39 | 26.91 | 26.27 | 26.70 | 25.81 | 39,082,928 |
| Apr 29, 2026 | 26.36 | 26.55 | 26.20 | 26.26 | 25.38 | 29,969,699 |
| Apr 28, 2026 | 27.53 | 27.58 | 26.32 | 26.48 | 25.59 | 58,079,040 |
| Apr 27, 2026 | 27.05 | 27.34 | 26.79 | 26.79 | 25.89 | 34,764,213 |
| Apr 24, 2026 | 26.69 | 27.30 | 26.58 | 27.00 | 26.10 | 42,500,211 |
| Apr 23, 2026 | 26.76 | 26.83 | 26.38 | 26.67 | 25.78 | 38,718,407 |
| Apr 22, 2026 | 27.35 | 27.39 | 26.74 | 26.80 | 25.91 | 35,246,788 |
| Apr 21, 2026 | 27.52 | 27.62 | 27.20 | 27.31 | 26.40 | 29,833,009 |
| Apr 20, 2026 | 27.59 | 27.84 | 27.51 | 27.52 | 26.60 | 25,023,004 |
| Apr 17, 2026 | 27.33 | 27.67 | 27.12 | 27.56 | 26.64 | 30,080,405 |
| Apr 16, 2026 | 27.20 | 27.48 | 27.15 | 27.22 | 26.31 | 21,905,297 |
| Apr 15, 2026 | 27.18 | 27.36 | 26.97 | 27.19 | 26.28 | 29,648,942 |
| Apr 14, 2026 | 27.20 | 27.31 | 27.07 | 27.11 | 26.20 | 24,558,929 |
| Apr 13, 2026 | 26.83 | 27.57 | 26.68 | 27.34 | 26.43 | 44,156,223 |
| Apr 10, 2026 | 27.32 | 27.36 | 26.77 | 26.92 | 26.02 | 27,882,376 |
| Apr 9, 2026 | 27.21 | 27.50 | 27.18 | 27.22 | 26.31 | 27,047,559 |
| Apr 8, 2026 | 27.25 | 27.49 | 26.96 | 27.47 | 26.55 | 33,789,069 |
| Apr 7, 2026 | 27.66 | 27.68 | 26.78 | 27.10 | 26.20 | 46,620,512 |
| Apr 6, 2026 | 28.19 | 28.23 | 27.81 | 27.83 | 26.90 | 25,169,255 |
| Apr 2, 2026 | 28.50 | 28.75 | 28.22 | 28.32 | 27.37 | 30,920,609 |
| Apr 1, 2026 | 28.27 | 28.64 | 28.04 | 28.55 | 27.60 | 44,208,492 |
| Mar 31, 2026 | 27.99 | 28.31 | 27.79 | 28.08 | 27.14 | 44,841,498 |
| Mar 30, 2026 | 27.42 | 27.82 | 27.15 | 27.77 | 26.84 | 46,696,029 |
| Mar 27, 2026 | 27.73 | 27.77 | 27.02 | 27.04 | 26.14 | 29,124,601 |
| Mar 26, 2026 | 27.25 | 27.80 | 27.24 | 27.57 | 26.65 | 28,834,961 |
| Mar 25, 2026 | 27.18 | 27.53 | 27.04 | 27.28 | 26.37 | 37,603,861 |
| Mar 24, 2026 | 26.60 | 27.13 | 26.44 | 26.96 | 26.06 | 35,605,271 |
| Mar 23, 2026 | 27.03 | 27.19 | 26.63 | 26.77 | 25.88 | 42,945,223 |
| Mar 20, 2026 | 27.41 | 27.55 | 26.80 | 26.97 | 26.07 | 66,805,681 |
| Mar 19, 2026 | 27.29 | 27.73 | 27.25 | 27.41 | 26.49 | 47,939,550 |
| Mar 18, 2026 | 27.14 | 27.38 | 26.84 | 27.32 | 26.41 | 47,478,273 |
| Mar 17, 2026 | 26.82 | 27.76 | 26.82 | 27.45 | 26.53 | 60,097,473 |
| Mar 16, 2026 | 26.70 | 26.89 | 26.52 | 26.61 | 25.72 | 28,551,476 |
| Mar 13, 2026 | 27.02 | 27.28 | 26.57 | 26.58 | 25.69 | 34,270,811 |
| Mar 12, 2026 | 27.11 | 27.12 | 26.63 | 26.86 | 25.96 | 38,542,832 |
| Mar 11, 2026 | 27.20 | 27.41 | 27.00 | 27.30 | 26.39 | 40,560,132 |
| Mar 10, 2026 | 26.82 | 27.29 | 26.52 | 27.16 | 26.25 | 42,814,600 |
| Mar 9, 2026 | 26.91 | 27.11 | 26.36 | 26.81 | 25.91 | 42,789,542 |
| Mar 6, 2026 | 26.54 | 27.13 | 26.23 | 27.05 | 26.15 | 53,181,848 |
| Mar 5, 2026 | 26.39 | 26.71 | 26.20 | 26.61 | 25.72 | 38,908,617 |
| Mar 4, 2026 | 26.77 | 26.78 | 26.35 | 26.62 | 25.73 | 30,893,515 |
| Mar 3, 2026 | 26.72 | 26.95 | 26.35 | 26.58 | 25.69 | 41,486,090 |
| Mar 2, 2026 | 27.57 | 27.61 | 27.17 | 27.26 | 26.35 | 41,321,691 |
| Feb 27, 2026 | 27.16 | 27.67 | 27.09 | 27.65 | 26.73 | 41,879,693 |
| Feb 26, 2026 | 27.26 | 27.27 | 26.87 | 27.10 | 26.20 | 30,508,283 |
| Feb 25, 2026 | 27.05 | 27.29 | 26.73 | 27.09 | 26.18 | 32,680,322 |
| Feb 24, 2026 | 27.14 | 27.42 | 27.08 | 27.14 | 26.23 | 34,686,061 |
| Feb 23, 2026 | 26.55 | 27.11 | 26.50 | 27.06 | 26.16 | 34,166,080 |
| Feb 20, 2026 | 26.71 | 26.77 | 26.36 | 26.65 | 25.76 | 44,786,926 |
| Feb 19, 2026 | 27.37 | 27.40 | 26.58 | 26.86 | 25.96 | 40,316,786 |
| Feb 18, 2026 | 27.44 | 27.48 | 27.20 | 27.37 | 26.46 | 24,779,774 |
| Feb 17, 2026 | 27.84 | 27.87 | 27.20 | 27.37 | 26.46 | 32,119,860 |
| Feb 13, 2026 | 27.60 | 27.94 | 27.55 | 27.58 | 26.66 | 36,986,727 |
| Feb 12, 2026 | 27.65 | 27.89 | 27.41 | 27.47 | 26.55 | 58,805,105 |
| Feb 11, 2026 | 27.55 | 27.94 | 27.31 | 27.73 | 26.80 | 41,699,330 |
| Feb 10, 2026 | 27.18 | 27.73 | 27.09 | 27.61 | 26.69 | 43,760,600 |
| Feb 9, 2026 | 27.18 | 27.36 | 26.79 | 27.05 | 26.15 | 49,288,175 |
| Feb 6, 2026 | 26.67 | 27.37 | 26.52 | 27.22 | 26.31 | 50,691,575 |
| Feb 5, 2026 | 26.76 | 27.19 | 26.46 | 26.49 | 25.61 | 72,650,731 |
| Feb 4, 2026 | 25.88 | 26.98 | 25.86 | 26.78 | 25.89 | 83,025,839 |
| Feb 3, 2026 | 25.36 | 26.11 | 25.26 | 25.77 | 24.91 | 91,964,912 |
| Feb 2, 2026 | 26.42 | 26.68 | 26.35 | 26.66 | 25.77 | 52,129,516 |
| Jan 30, 2026 | 26.13 | 26.47 | 25.90 | 26.44 | 25.56 | 51,599,439 |
| Jan 29, 2026 | 25.90 | 26.23 | 25.88 | 26.10 | 25.23 | 44,373,803 |
| Jan 28, 2026 | 26.27 | 26.39 | 25.75 | 25.86 | 25.00 | 44,976,694 |
| Jan 27, 2026 | 25.94 | 26.83 | 25.90 | 26.50 | 25.61 | 75,575,387 |
| Jan 26, 2026 | 25.63 | 25.92 | 25.59 | 25.88 | 25.02 | 41,441,866 |
| Jan 23, 2026$0.43 dividend | 25.58 | 25.68 | 25.51 | 25.65 | 24.79 | 45,402,334 |
| Jan 22, 2026 | 25.90 | 26.31 | 25.75 | 26.10 | 24.81 | 49,883,920 |
| Jan 21, 2026 | 25.47 | 25.92 | 25.38 | 25.89 | 24.61 | 47,264,124 |
| Jan 20, 2026 | 25.43 | 25.65 | 25.09 | 25.52 | 24.26 | 55,425,394 |
| Jan 16, 2026 | 25.89 | 25.89 | 25.55 | 25.65 | 24.38 | 59,470,570 |
| Jan 15, 2026 | 25.55 | 25.89 | 25.25 | 25.89 | 24.61 | 55,263,211 |
| Jan 14, 2026 | 25.23 | 25.71 | 25.20 | 25.58 | 24.32 | 53,738,090 |
| Jan 13, 2026 | 25.32 | 25.39 | 24.97 | 25.15 | 23.91 | 47,656,110 |
| Jan 12, 2026 | 25.57 | 25.77 | 25.09 | 25.27 | 24.02 | 50,256,307 |
| Jan 9, 2026 | 25.34 | 25.55 | 25.23 | 25.48 | 24.22 | 34,190,182 |
| Jan 8, 2026 | 25.18 | 25.56 | 25.12 | 25.29 | 24.04 | 42,977,333 |
| Jan 7, 2026 | 25.59 | 25.81 | 25.14 | 25.28 | 24.03 | 51,395,756 |
| Jan 6, 2026 | 25.18 | 26.00 | 25.18 | 25.43 | 24.18 | 50,977,282 |
| Jan 5, 2026 | 25.20 | 25.40 | 24.95 | 25.17 | 23.93 | 52,620,900 |
| Jan 2, 2026 | 24.98 | 25.30 | 24.83 | 25.18 | 23.94 | 35,976,669 |
| Dec 31, 2025 | 24.96 | 25.02 | 24.88 | 24.90 | 23.67 | 29,409,238 |
| Dec 30, 2025 | 25.01 | 25.05 | 24.92 | 24.99 | 23.76 | 28,821,740 |
| Dec 29, 2025 | 25.05 | 25.20 | 24.97 | 25.00 | 23.77 | 33,067,670 |
| Dec 26, 2025 | 25.02 | 25.11 | 24.92 | 25.09 | 23.85 | 21,617,814 |
| Dec 24, 2025 | 24.92 | 25.14 | 24.91 | 25.03 | 23.80 | 19,328,545 |
| Dec 23, 2025 | 25.26 | 25.34 | 24.83 | 24.88 | 23.65 | 43,692,855 |
| Dec 22, 2025 | 25.20 | 25.40 | 25.13 | 25.21 | 23.97 | 38,758,872 |
| Dec 19, 2025 | 25.01 | 25.52 | 24.98 | 25.19 | 23.95 | 87,589,966 |
| Dec 18, 2025 | 25.01 | 25.23 | 24.98 | 25.04 | 23.80 | 47,062,505 |
| Dec 17, 2025 | 25.40 | 25.49 | 25.03 | 25.04 | 23.80 | 61,255,280 |
| Dec 16, 2025 | 26.44 | 26.50 | 24.92 | 25.53 | 24.27 | 111,695,467 |
| Dec 15, 2025 | 25.82 | 26.65 | 25.81 | 26.43 | 25.13 | 60,360,028 |
| Dec 12, 2025 | 25.84 | 26.04 | 25.72 | 25.85 | 24.57 | 51,599,710 |
| Dec 11, 2025 | 25.80 | 26.04 | 25.61 | 25.80 | 24.53 | 35,570,246 |
| Dec 10, 2025 | 25.49 | 25.79 | 25.22 | 25.78 | 24.51 | 43,635,410 |
| Dec 9, 2025 | 26.00 | 26.13 | 25.13 | 25.33 | 24.08 | 43,483,806 |
| Dec 8, 2025 | 26.04 | 26.19 | 25.76 | 25.77 | 24.50 | 45,209,347 |
| Dec 5, 2025 | 25.77 | 26.12 | 25.64 | 26.03 | 24.75 | 47,443,701 |
| Dec 4, 2025 | 25.63 | 25.74 | 25.35 | 25.70 | 24.43 | 35,453,966 |
| Dec 3, 2025 | 25.32 | 25.89 | 25.30 | 25.57 | 24.31 | 56,121,174 |
| Dec 2, 2025 | 25.32 | 25.32 | 25.04 | 25.15 | 23.91 | 43,826,986 |
| Dec 1, 2025 | 25.76 | 25.94 | 25.23 | 25.27 | 24.02 | 53,198,560 |
| Nov 28, 2025 | 25.85 | 25.86 | 25.66 | 25.74 | 24.47 | 22,627,577 |
| Nov 26, 2025 | 25.70 | 25.81 | 25.58 | 25.71 | 24.44 | 33,461,046 |
| Nov 25, 2025 | 25.37 | 25.97 | 25.36 | 25.72 | 24.45 | 39,130,262 |
| Nov 24, 2025 | 25.11 | 25.47 | 25.05 | 25.22 | 23.98 | 63,074,949 |
| Nov 21, 2025 | 24.59 | 25.52 | 24.59 | 25.04 | 23.80 | 73,079,369 |
| Nov 20, 2025 | 24.89 | 25.00 | 24.28 | 24.40 | 23.20 | 51,983,224 |
| Nov 19, 2025 | 25.35 | 25.50 | 24.72 | 24.88 | 23.65 | 62,000,199 |
| Nov 18, 2025 | 25.05 | 25.51 | 24.98 | 25.45 | 24.19 | 66,511,756 |
| Nov 17, 2025 | 25.11 | 25.57 | 24.95 | 25.08 | 23.84 | 88,042,246 |
| Nov 14, 2025 | 25.67 | 25.77 | 24.97 | 25.06 | 23.82 | 96,507,648 |
| Nov 13, 2025 | 25.94 | 26.48 | 25.67 | 25.79 | 24.52 | 123,083,106 |
| Nov 12, 2025 | 25.39 | 25.95 | 25.25 | 25.87 | 24.59 | 96,008,033 |
| Nov 11, 2025 | 24.49 | 25.51 | 24.44 | 25.51 | 24.25 | 139,673,794 |
| Nov 10, 2025 | 24.66 | 24.89 | 23.91 | 24.39 | 23.19 | 148,958,624 |
| Nov 7, 2025$0.43 dividend | 24.33 | 24.63 | 24.11 | 24.43 | 23.23 | 117,794,498 |
| Nov 6, 2025 | 24.75 | 25.13 | 24.54 | 24.85 | 23.21 | 124,137,172 |
| Nov 5, 2025 | 24.38 | 24.67 | 24.16 | 24.61 | 22.99 | 107,240,924 |
| Nov 4, 2025 | 24.39 | 25.20 | 24.20 | 24.30 | 22.70 | 166,161,967 |
| Nov 3, 2025 | 24.59 | 24.75 | 24.41 | 24.66 | 23.04 | 140,871,289 |
| Oct 31, 2025 | 24.28 | 24.73 | 24.16 | 24.65 | 23.03 | 132,697,441 |
| Oct 30, 2025 | 24.31 | 24.70 | 24.15 | 24.29 | 22.69 | 157,478,009 |
| Oct 29, 2025 | 24.53 | 24.62 | 24.23 | 24.29 | 22.69 | 65,438,433 |
| Oct 28, 2025 | 24.78 | 24.78 | 24.38 | 24.50 | 22.89 | 50,152,370 |
| Oct 27, 2025 | 24.74 | 24.80 | 24.63 | 24.77 | 23.14 | 34,974,859 |
| Oct 24, 2025 | 24.70 | 24.83 | 24.68 | 24.76 | 23.13 | 27,429,169 |
| Oct 23, 2025 | 24.76 | 24.78 | 24.51 | 24.67 | 23.05 | 34,219,939 |
| Oct 22, 2025 | 24.79 | 24.93 | 24.62 | 24.72 | 23.09 | 48,662,938 |
| Oct 21, 2025 | 24.72 | 24.96 | 24.60 | 24.85 | 23.21 | 40,726,922 |
| Oct 20, 2025 | 24.57 | 24.73 | 24.51 | 24.69 | 23.07 | 35,856,842 |
| Oct 17, 2025 | 24.20 | 24.53 | 24.16 | 24.51 | 22.90 | 40,101,861 |
| Oct 16, 2025 | 24.44 | 24.61 | 24.21 | 24.23 | 22.64 | 44,389,991 |
| Oct 15, 2025 | 24.49 | 24.58 | 24.21 | 24.39 | 22.79 | 47,729,799 |
| Oct 14, 2025 | 24.65 | 24.79 | 24.48 | 24.52 | 22.91 | 42,277,035 |
| Oct 13, 2025 | 24.84 | 24.95 | 24.61 | 24.73 | 23.10 | 45,356,617 |
| Oct 10, 2025 | 25.26 | 25.42 | 24.62 | 24.78 | 23.15 | 64,963,949 |
| Oct 9, 2025 | 25.78 | 25.90 | 25.21 | 25.24 | 23.58 | 47,278,671 |
| Oct 8, 2025 | 26.42 | 26.50 | 25.63 | 25.68 | 23.99 | 48,693,344 |
| Oct 7, 2025 | 26.42 | 26.58 | 26.05 | 26.27 | 24.54 | 47,744,194 |
| Oct 6, 2025 | 27.27 | 27.36 | 26.39 | 26.43 | 24.69 | 62,945,613 |
| Oct 3, 2025 | 27.20 | 27.69 | 27.04 | 27.37 | 25.57 | 70,524,014 |
| Oct 2, 2025 | 26.93 | 27.17 | 26.62 | 27.08 | 25.30 | 69,684,073 |
| Oct 1, 2025 | 25.97 | 27.45 | 25.58 | 27.21 | 25.42 | 150,879,897 |
| Sep 30, 2025 | 23.85 | 25.63 | 23.81 | 25.48 | 23.80 | 164,867,295 |
| Sep 29, 2025 | 23.79 | 23.86 | 23.64 | 23.85 | 22.28 | 39,184,350 |
| Sep 26, 2025 | 23.73 | 23.81 | 23.61 | 23.76 | 22.20 | 33,441,186 |
| Sep 25, 2025 | 24.09 | 24.15 | 23.58 | 23.60 | 22.05 | 56,740,264 |
| Sep 24, 2025 | 24.17 | 24.18 | 23.98 | 24.09 | 22.50 | 39,669,361 |
| Sep 23, 2025 | 24.10 | 24.36 | 24.05 | 24.13 | 22.54 | 38,975,248 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
Need daily prices for every ticker, in code?
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver API
Pfizer Inc. Executive Compensation
We estimate that -- received a compensation of -- in --, making them the highest paid executive at PFE, per a recent SEC DEF 14A filing. We estimate that the median employee at PFIZER INC is paid $91,507.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|